Summary
Previous studies demonstrated that higher biliary protein is associated with reduced metastability of bile. This study attempted to examine the induced effect of ursodeoxycholate on metastability of bile by measuring the nucleation time and biliary protein in cholesterol gallstone patients. Thirty-seven patients with functioning gallbladders were studied 10 control patients without gallstones and 27 with cholesterol gallstones. Ten of 27 cholesterol gallstone patients were treated with ursodeoxycholate (600 mg/ day) prior to surgery. Twelve of 17 untreated gallstone patients had cholesterol crystals in gallbladder bile while cholesterol crystals were absent in the ursodeoxycholate-treated gallstone patients and in the controls. Total protein concentration and cholesterol saturation index were significantly greater in the untreated gallstone patients with crystals than in those without crystals in bile. The treatment with ursodeoxycholate significantly decreased biliary protein concentration and cholesterol saturation index associated with the prolonged nucleation time. Cholesterol nucleation time correlated with biliary total protein concentration and cholesterol saturation index but not with total lipid concentration. It is concluded from the present study that ursodeoxycholate decreases biliary protein thereby partly increasing metastability of gallbladder bile.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Chijiiwa K, Hirota I, Noshiro H, et al: Comparative effects of chenodeoxycholate and ursodeoxycholate on bile metastability in cholesterol gallstone patients. Gastroenterology 1991;100:A313.
Sahlin S, Thyberg P, Ahlberg J, et al: Distribution of cholesterol between vesicles and micelles in human gallbladder bile: influence of treatment with chenodeoxycholic acid and ursodeoxycholic acid. Hepatology 1991;13:104–110.
Tazuma S, Sasaki H, Mizuno S, et al: Effect of ursodeoxycholic acid administration on nucleation time in human gallbladder bile. Gastroenterology 1989;97:173–178.
Jungst D, Brenner G, Pratschke E, et al: Low-dose Ursodeoxycholic acid prolongs cholesterol nucleation time in gallbladder bile of patients with cholesterol gallstones. J Hepatol 1989;8:1–6.
Holzbach RT, Marsh M, Olszewski M, et al: Cholestertol solubility in bile: evidence that supersaturated bile is frequent in healthy man. J Clin Invest 1973;52:1467–1469.
Holan KR, Holzbach RT, Hermann RE, et al: Nucleation time: a key factor in the pathogenesis of cholesterol gallstone disease. Gastroenterology 1979;77:611–617.
Levy PF, Smith BF and Lamont, JT. Human gallbladder mucin accelerates nucleation of cholesterol in human bile. Gastroenterology 1984;87:270–275.
Groen AK, Noordam C, Drapers JAG, et al: Isolation of a potent cholesterol nucleation-promoting activity from human gallbladder bile: role in the pathogenesis of gallstone disease. Hepatology 1990;11:525–535.
Holzbach RT, Kibe A, Thiel E, et al: Biliary proteins. Unique inhibitors of cholesterol crystal nucleation in human gallbladder bile. J Clin Invest 1984;74:35–45.
Strasberg, SM, Toth JL, Gallinger S, et al: High protein and total lipid concentration are associated with reduced metastability of bile in an early stage of cholesterol gallstone formation. Gastroenterology 1990;98:739–746.
Magnuson TH, Lillenoe KD, Scheeres DE, et al: Altered bile composition during cholestserol gallstone formation: cause or effect? J Surg Res 1990;48:584–589.
Groen AK, Ottenhoff R, Noordam C, et al: Cholesterol nucleating promoting activity shifts cholesterol from the micellar to the vesicular phase (abstract). Gastroenterology 1987;92:1737.
Chijiiwa K, Nakayama F: Simultaneous microanalysis of bile acids and cholesterol in bile by glass capillary column gas chromatography. J Chromatogr 1988;431:17–25.
Bartlett GR: Phophorus assay in column chromatography. J Biol Chem 1959;234:466–468.
Carey MC: Critical tables for calculating the cholesterol saturation of native bile. J Lipid Res 1978;19:945–955.
Udenfriend S, Stein S, Bohelen P, et al: Fluorescamine: a reagent for assay of amino acids, peptides, proteins and primary amines in the picomole range. Science 1972;178:871–872.
Yamazaki K, Powers SP, LaRusso NF: Biliary proteins: assessment of quantitative techniques and comparison in gallstone and nongallstone subjects. J Lipid Res 1988;29:1055–1063.
Gallinger S, Harvey PRC, Petrunka CN, et al: Biliary proteins and the nucleation defect in cholesterol cholelithiasis. Gastroenterology 1987;92:867–875.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chijiiwa, K., Hirota, I. & Noshiro, H. Decreased protein concentration and improved metastability of bile induced by ursodeoxycholate. Gastroenterol Jpn 27, 88–94 (1992). https://doi.org/10.1007/BF02775069
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02775069